Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Excipients
Sort By
Newest First
1 / 2
Viscosity Reduction
Viscosity Reduction with An Excipient Platform and Feasibility Testing Service
Alana Gouveia
MilliporeSigma
PAO-08-23-CL-03
Aug 10, 2023
Alternative Excipient
Preparing Today for a Potential Ban on Titanium Dioxide in Pharmaceutical Drug Products
Almut von der Brelie
MilliporeSigma
PAO-08-23-CL-01
Aug 03, 2023
Modified-Release Drug Formulations
Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores
Donald Loveday, Ph.D.; Bill McCarthy; Doug Hovey
SPI Pharma
PAO-05-23-CL-06
Jun 06, 2023
Distribution
Redefining Innovation and Growth in Pharmaceutical Distribution
Ernest de Freitas
Univar Solutions
PAO-06-23-CL-03
Jun 06, 2023
3D Printing
Advancing Extrusion-Based 3D Printing for Drug Production
Thomas Kipping, Ph.D.; Xianghao Zuo, Ph.D.
MilliporeSigma
PAO-11-022-CL-14
Nov 29, 2022
Sweeteners
High-Intensity Sweeteners for Taste Optimization
Almut von der Brelie
MilliporeSigma
PAO-11-022-CL-12
Nov 28, 2022
Taste Masking Formulations
Formulating Flexibility with ActiMask® Taste Masking
SPI Pharma
PAO-10-022-CL-05
Oct 25, 2022
Lipid Excipients
Regulatory Considerations for Lipid Excipients
Claudia Widmann; Estelle Beguin Ph.D.
MilliporeSigma
PAO-07-022-CL-04
Aug 15, 2022
Excipient Quality Assurance
Assuring Excipient Quality for Parenteral Products
Lars Albermann, Ph.D.; Markus Greulich
MilliporeSigma
PA287
Jul 28, 2022
Advanced Excipients
How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs
Daniel Joseph Price, Ph.D.
MilliporeSigma
PAO-04-022-CL-07
Apr 27, 2022
Excipients
Enabling Stable, High-Viscosity Injectable Drug Products with New Excipient Combinations
Tobias Rosenkranz, Ph.D.; Sara Kalman
MilliporeSigma
PAO-01-22-CL-02
Mar 12, 2022
Formulation
Incorporating Patient Voices from the Start of Drug Development
Bill McCarthy
SPI Pharma
PAO-01-22-R250-10
Jan 28, 2022
Formulation
Accelerating Biologics Development with High-Quality Protein Stabilization Excipients
Balu Guduri; Nelli Erwin, Ph.D.
MilliporeSigma
PAO-11-21-CL-12
Nov 18, 2021
Tablet Coating
An Easy-to-Use Tablet Coating Polymer to Increase Coating Process Efficiency and Flexibility
Thomas Kipping, Ph.D.
MilliporeSigma
PAO-09-21-CL-06
Sep 14, 2021
Orally Disintegrating Tablets
A Revolutionary Excipient Platform for Super-Fast Disintegrating ODTs
Bill McCarthy; Geetha Thanga Mariappan, Ph.D.
SPI Pharma
PAO-07-21-CL-03
Jul 13, 2021
Hot Melt Extrusion
Solving Solubility Challenges with a Polyvinyl Alcohol Excipient and Hot Melt Extrusion
Daniel Joseph Price, Ph.D.; Thomas Kipping, Ph.D.
MilliporeSigma
PAP-Q4-20-CL-016
Dec 09, 2020
The Future of Healthcare
How Does SPI Pharma Envision the Future of the Pharma/Biopharma Industry?
SPI Pharma
PAP-Q4-20-RT2-009
Dec 09, 2020
Orally Disintegrating Tablets
Qualifying ODT Excipient Systems Beyond Disintegration Performance
Adela Kasselkus, Ph.D.; Hans-Leonhard Ohrem
MilliporeSigma
PAO-10-20-CL-03
Oct 27, 2020
Wet Granulation
The Application of Mannitol In Wet Granulation
Hans-Leonhard Ohrem
MilliporeSigma
PAO-10-20-CL-01
Oct 06, 2020
The Future of Healthcare
How Is SPI Pharma Evolving its Business Model to Meet the Future of Healthcare?
SPI Pharma
PAP-Q3-20-RT2-004
Sep 29, 2020
1 / 2
